Mendelian randomization supports causality between gut microbiota and chronic hepatitis B

Quanzheng Zhang1, Jinhua Zhou1, Xiaoxiao Zhang2

  • 1Department of Critical Care Medicine, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China.

Frontiers in Microbiology
|September 1, 2023
PubMed
Summary

This study identified specific gut microbes that may protect against or increase the risk of chronic hepatitis B (CHB). These findings could inform future fecal microbiota transplantation therapies for CHB.

Related Concept Videos